NDUFC1: A Potential Cancer Treatment and Biomarker (G4717)

Target Name: NDUFC1

NCBI ID: G4717

NDUFC1

NDUFC1: A Potential Cancer Treatment and Biomarker

National DNA User Forum (NDUFC1) is a key regulator of gene expression in the cell. It plays a crucial role in the development, maintenance, and progression of various diseases, including cancer. Researchers are constantly exploring new drug targets and biomarkers to treat these diseases. One such potential drug target is NDUFC1, which has been identified as a promising candidate for cancer treatment.

NDUFC1 is a non-coding RNA molecule that is expressed in various tissues and cells throughout the body. It is a key regulator of gene expression, and it has been shown to play a crucial role in the development and progression of various diseases, including cancer.

One of the key functions of NDUFC1 is its role in cell-cycle regulation. The cell cycle is the process by which a cell grows, replicates its DNA, and divides. NDUFC1 is involved in regulating the length and timing of cell cycles, which is critical for the development and progression of cancer.

In addition to its role in cell-cycle regulation, NDUFC1 is also involved in the regulation of apoptosis, which is the process by which a cell undergoes programmed cell death. Apoptosis is a natural and essential process that helps the body remove damaged or dysfunctional cells. However, in cancer cells, apoptosis becomes aberrant, leading to the development and progression of cancer.

NDUFC1 has also been shown to be involved in the regulation of cell-signaling pathways. These pathways are the processes by which cells communicate with each other and with their surroundings, and they play a crucial role in the development and progression of cancer.NDUFC1 is involved in several of these pathways, including the TGF-β pathway, which is a key pathway involved in the development and progression of cancer.

In addition to its role in cell-cycle regulation and apoptosis, NDUFC1 is also involved in the regulation of inflammation. Inflammation is a natural response of the immune system to injury or infection, and it is critical for the development and progression of many diseases, including cancer. NDUFC1 is involved in the regulation of inflammation, and it has been shown to play a crucial role in the development and progression of cancer.

NDUFC1 is also a promising candidate for cancer treatment because of its ability to interact with several drug targets. Researchers have identified several potential drug targets that are involved in the regulation of NDUFC1, including the TGF-β pathway, the PI3K/Akt pathway, and the NF-kappa-B pathway. These drug targets are involved in a wide range of cellular processes, including cell-cycle regulation, apoptosis, and inflammation.

In addition to its potential as a drug target, NDUFC1 is also a promising biomarker for cancer. Several studies have shown that NDUFC1 levels are elevated in various types of cancer, and that targeting NDUFC1 with drugs can be effective in treating these diseases. In addition, NDUFC1 has also been shown to be a potential biomarker for monitoring the effectiveness of cancer treatments.

In conclusion, NDUFC1 is a promising candidate for cancer treatment due to its role in cell-cycle regulation, apoptosis, and inflammation. Its ability to interact with multiple drug targets makes it an attractive target for drug development, and its potential as a biomarker for cancer treatment makes it an important area of research. As research continues to advance, it is likely that the role of NDUFC1 in the development and progression of cancer will become increasingly understood, and its potential as a drug and biomarker will be realized.

Protein Name: NADH:ubiquinone Oxidoreductase Subunit C1

Functions: Accessory subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I), that is believed not to be involved in catalysis. Complex I functions in the transfer of electrons from NADH to the respiratory chain. The immediate electron acceptor for the enzyme is believed to be ubiquinone

The "NDUFC1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about NDUFC1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets